Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Chlamydia and chronic arthritis.

Carter JD, Inman RD, Whittum-Hudson J, Hudson AP.

Ann Med. 2012 Dec;44(8):784-92. doi: 10.3109/07853890.2011.606830. Epub 2011 Aug 24. Review.

PMID:
21864020
2.

The role of Chlamydia and Chlamydophila infections in reactive arthritis.

Rizzo A, Domenico MD, Carratelli CR, Paolillo R.

Intern Med. 2012;51(1):113-7. Epub 2012 Jan 1.

3.

Molecular biology of infectious agents in chronic arthritis.

Gérard HC, Whittum-Hudson JA, Carter JD, Hudson AP.

Rheum Dis Clin North Am. 2009 Feb;35(1):1-19. doi: 10.1016/j.rdc.2009.03.011. Review.

PMID:
19480994
5.

Chlamydiae as etiologic agents in chronic undifferentiated spondylarthritis.

Carter JD, Gérard HC, Espinoza LR, Ricca LR, Valeriano J, Snelgrove J, Oszust C, Vasey FB, Hudson AP.

Arthritis Rheum. 2009 May;60(5):1311-6. doi: 10.1002/art.24431.

6.

The pathogenic role of Chlamydia in spondyloarthritis.

Gérard HC, Whittum-Hudson JA, Carter JD, Hudson AP.

Curr Opin Rheumatol. 2010 Jul;22(4):363-7. doi: 10.1097/BOR.0b013e32833952cb. Review.

PMID:
20414116
7.

Persistent Chlamydiae and chronic arthritis.

Villareal C, Whittum-Hudson JA, Hudson AP.

Arthritis Res. 2002;4(1):5-9. Epub 2001 Oct 8. Review.

8.

Frequency of apolipoprotein E (APOE) allele types in patients with Chlamydia-associated arthritis and other arthritides.

Gérard HC, Wang GF, Balin BJ, Schumacher HR, Hudson AP.

Microb Pathog. 1999 Jan;26(1):35-43.

PMID:
9973579
9.

The evolving story of Chlamydia-induced reactive arthritis.

Carter JD, Hudson AP.

Curr Opin Rheumatol. 2010 Jul;22(4):424-30. doi: 10.1097/BOR.0b013e32833a43a2. Review.

PMID:
20445454
10.

[Choice of antimicrobial drug for infections caused by Chlamydia trachomatis and Chlamydophila pneumoniae].

Zele-Starcević L, Plecko V, Budimir A, Kalenić S.

Acta Med Croatica. 2004;58(4):329-33. Review. Croatian.

PMID:
15700690
11.

The intracellular life of chlamydiae.

Hammerschlag MR.

Semin Pediatr Infect Dis. 2002 Oct;13(4):239-48. Review.

PMID:
12491229
12.

Chlamydia pneumoniae--a new causative agent of reactive arthritis and undifferentiated oligoarthritis.

Braun J, Laitko S, Treharne J, Eggens U, Wu P, Distler A, Sieper J.

Ann Rheum Dis. 1994 Feb;53(2):100-5.

13.

Recent advances and future directions in understanding and treating Chlamydia-induced reactive arthritis.

Carter JD, Hudson AP.

Expert Rev Clin Immunol. 2017 Mar;13(3):197-206. doi: 10.1080/1744666X.2017.1233816. Epub 2016 Sep 20. Review.

PMID:
27627462
14.

Lower prevalence of Chlamydia pneumoniae DNA compared with Chlamydia trachomatis DNA in synovial tissue of arthritis patients.

Schumacher HR Jr, Gérard HC, Arayssi TK, Pando JA, Branigan PJ, Saaibi DL, Hudson AP.

Arthritis Rheum. 1999 Sep;42(9):1889-93.

15.

Cytokine and chemokine mRNA produced in synovial tissue chronically infected with Chlamydia trachomatis and C. pneumoniae.

Gerard HC, Wang Z, Whittum-Hudson JA, El-Gabalawy H, Goldbach-Mansky R, Bardin T, Schumacher HR, Hudson AP.

J Rheumatol. 2002 Sep;29(9):1827-35.

PMID:
12233874
16.

Combination antibiotics as a treatment for chronic Chlamydia-induced reactive arthritis: a double-blind, placebo-controlled, prospective trial.

Carter JD, Espinoza LR, Inman RD, Sneed KB, Ricca LR, Vasey FB, Valeriano J, Stanich JA, Oszust C, Gerard HC, Hudson AP.

Arthritis Rheum. 2010 May;62(5):1298-307. doi: 10.1002/art.27394.

17.

Synovial Chlamydia trachomatis in patients with reactive arthritis/Reiter's syndrome are viable but show aberrant gene expression.

Gérard HC, Branigan PJ, Schumacher HR Jr, Hudson AP.

J Rheumatol. 1998 Apr;25(4):734-42.

PMID:
9558178
18.

More than just innate immunity: comparative analysis of Chlamydophila pneumoniae and Chlamydia trachomatis effects on host-cell gene regulation.

Hess S, Peters J, Bartling G, Rheinheimer C, Hegde P, Magid-Slav M, Tal-Singer R, Klos A.

Cell Microbiol. 2003 Nov;5(11):785-95.

PMID:
14531894
19.

Differential expression of three Chlamydia trachomatis hsp60-encoding genes in active vs. persistent infections.

Gérard HC, Whittum-Hudson JA, Schumacher HR, Hudson AP.

Microb Pathog. 2004 Jan;36(1):35-9.

PMID:
14643638

Supplemental Content

Support Center